Zymeworks
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.About ZYME
Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).
ZYME Key Statistics
Stock Snapshot
As of today, Zymeworks(ZYME) shares are valued at $25.31. The company's market cap stands at 1.81B, with a P/E ratio of -12.56.
On 2026-08-17, Zymeworks(ZYME) stock moved within a range of $24.94 to $25.80. With shares now at $25.31, the stock is trading +1.5% above its intraday low and -1.9% below the session's peak.
Trading volume for Zymeworks(ZYME) stock has reached 441.12K, versus its average volume of 544.45K.
The stock's 52-week range extends from a low of $13.48 to a high of $29.75.
The stock's 52-week range extends from a low of $13.48 to a high of $29.75.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.